Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. Acute oral complications of cancer therapy
- Prof. Douglas E. Peterson
-
2. Oral candidiasis
- Prof. Lakshman P. Samaranayake
-
3. Cervical lymphadenopathy
- Prof. Graham Ogden
-
4. Chronic orofacial pain (COFP) disease or symptom? 1
- Dr. Theresa Gonzales
-
5. Chronic orofacial pain (COFP) disease or symptom? 2
- Dr. Theresa Gonzales
-
6. Drooling and sialorrhoea
- Prof. Pedro Diz Dios
- Dr. Jacobo Limeres Posse
-
7. Dry mouth (xerostomia and hypofunction)
- Prof. Mike Brennan
-
8. Halitosis - oral malodour
- Prof. John Greenman
-
9. Lumps and bumps in the mouth and lips
- Dr. Nicholas Kalavrezos
-
10. Lumps and swellings of the salivary glands 1
- Prof. Emeritus John D. Langdon
-
11. Lumps and swellings of the salivary glands 2
- Prof. Emeritus John D. Langdon
-
12. Management of the N0 neck
- Prof. Peter Brennan
-
13. Pigmented, brown or black lesions
- Dr. Sook-Bin Woo
-
14. Potentially lethal mouth diseases: premalignancy and oral cancer
- Dr. Giuseppe Ficarra
-
15. Potentially lethal mouth diseases: pemphigus
- Dr. Giuseppe Ficarra
-
16. Red lesions: vascular lesions
- Prof. James J. Sciubba
-
17. Red lesions: autoimmune and malignant conditions
- Prof. James J. Sciubba
-
18. Sensory and motor deficits
- Dr. Dimitris Malamos
-
20. Soreness and ulcers 2: blood diseases and infections
- Dr. Yazan Hassona
-
21. Soreness and ulcers 3: due to vesiculobullous disease 1
- Dr. Nikolaos Nikitakis
-
22. Soreness and ulcers 3: due to vesiculobullous disease 2
- Dr. Nikolaos Nikitakis
-
23. Soreness and ulcers 4: due to gastrointestinal disease
- Dr. Rachel Cowie
-
24. Soreness and ulcers 5: biology, diagnosis and management of cancer regimen 1
- Prof. Stephen T. Sonis
-
25. Soreness and ulcers 5: biology, diagnosis and management of cancer regimen 2
- Prof. Stephen T. Sonis
-
26. Trismus
- Prof. Tara Renton
-
27. White lesions - oral leukoplakia, a premalignant lesion
- Prof. Palle Holmstrup
-
28. White lesions - oral lichen planus, a premalignant condition
- Prof. Palle Holmstrup
Printable Handouts
Navigable Slide Index
- Introduction
- Approach for today's discussion
- National cancer institute: web resource
- Use of web resources
- Additional resources
- Why cancer patients develop oral complications?
- Chemotherapy and surgery/radiation
- Importance of collaboration
- Acute myelogenous leukemia
- Hematopoietic stem cells
- CBC and differential: acute leukemia
- Hepatic leukemic infiltrate
- Gastrointestinal leukemic infiltrate
- Gingival leukemic infiltrate
- Infection in myelosuppressed cancer patient
- High risk oral lesions
- Periodontal disease
- Retraction of flap
- Acute periodontal infection (patient 1)
- Acute periodontal infection (patient 2)
- Herpesvirus family
- Herpesvirus in immunocompetent patient
- Herpesvirus reactivation
- Herpesvirus in stem cell transplant patient
- Oral mucositis in high dose chemotherapy patient
- The perspective
- Oral mucositis - a key cancer therapy toxicity
- Incidence of oral mucositis
- Consequences of oral mucositis
- Mucositis: not just an epithelial process
- Pathobiology of mucositis
- CD4 distribution: normal oral mucosa
- Costs for treatment, head & neck cancer
- Toxicities impacting hematopoietic cell transplant
- Video-capsule endoscopy
- Normal jejunal mucosa
- Ulceration and bleeding
- Treatment of oral mucositis
- Palifermin
- Palifermin’s biologic pleotrophism
- Palifermin (KGF1): human buccal mucosa
- Advancing interprofessional approach
- Interprofessional approach: oncology team
- Ongoing evolution of guidelines
- Risk determinants
- Mucosal genetic determinants
- Glutathione-S-transferase
- Targeted cancer therapeutics
- MTOR inhibitor-associated stomatitis
- Hand-foot skin reaction (HFSR) due to sunitinib
- HFSR & oral stomatitis due to TKI
- Managing mTOR inhibitor-associated lesions
- mTOR inhibitor-associated lesions: treatment
- The future of cancer care:
- Message from ASCO’s 2015-2016 president
- Collaboration: dental and oncology teams
- Summary
- Thank you
Topics Covered
- Clinically significant oral toxicities of cancer treatment
- Clinical sequelae and economic impact
- Acute periodontal infection, acute mucosal viral infection, mucosal injury
- Neutropenic cancer patient
- Clinical presentation and interprofessional management
- Future directions of supportive care in cancer
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Peterson, D.E. (2017, February 28). Acute oral complications of cancer therapy [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 14, 2024, from https://doi.org/10.69645/EKXP5795.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Douglas E. Peterson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Cancer
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, I'm Douglas Peterson,
Professor of Oral Medicine
in the School of Dental Medicine
as well as Co-Chair of the program
in Head and Neck Cancer
and Oral Oncology
at the Neag Comprehensive Cancer Center
at UConn Health here in Farmington,
Connecticut in the USA.
Now, what I'd like
to talk with you about today
are selected "Acute Oral Complications
of Cancer Therapy".
0:25
The approach I have taken
for today's discussion
is to highlight selected
clinically significant
oral toxicities of cancer treatment.
The three toxicities that I've chosen
include: acute periodontal infection
in the neutropenic cancer patient,
acute oral mucosal viral infection,
again in the neutropenic cancer patient,
and then mucosal injury that's caused
either by high-dose chemotherapy
or head and neck radiation.
Or oral lesions
that are being now identified
as caused by targeted cancer therapies,
such as mTOR inhibitors.
These are recently identified lesions
over the last few years.
1:08
I'd like to recommend the following
National Cancer Institute web resource
for additional information
on today's presentation.
This is produced
by the National Cancer Institute
Physician Data Query
Cancer Information program.
And the specific website
I'd recommend is titled,
"Oral complications of chemotherapy
and head/neck radiation."
The website is listed on this slide.
I'm involved
in the production of this website
that's reviewed
by the National Cancer Institute.
And we're in the middle of some
strategic scientific updates
based on some recent advances
in the evidence.
And there are health professional
and patient versions
available for your use
and your patient's use.